Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117,273,296
-
Total 13F shares
-
67,352,038
-
Share change
-
+15,170,099
-
Total reported value
-
$240,821,480
-
Put/Call ratio
-
22%
-
Price per share
-
$3.58
-
Number of holders
-
111
-
Value change
-
+$52,193,878
-
Number of buys
-
58
-
Number of sells
-
43
Institutional Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q3 2019
As of 30 Sep 2019,
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) was held by
111 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
67,352,038 shares.
The largest 10 holders included
FEDERATED INVESTORS INC /PA/, Bain Capital Life Sciences Investors, LLC, BlackRock Inc., Senvest Management, LLC, Chicago Capital, LLC, VANGUARD GROUP INC, Bain Capital Public Equity Management II, LLC, RA CAPITAL MANAGEMENT, L.P., Rock Springs Capital Management LP, and UBS ASSET MANAGEMENT AMERICAS INC.
This page lists
111
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.